SCHEMBL7516206

SCHEMBL7516206

CCCCN(CCC(=O)OCC)c1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.46
CYP1A2 P05177 4/20 0.46
LMNA P02545 3/20 0.46
CHRM2 P08172 1/20 0.46
HTR1A P08908 1/20 0.46
GAA P10253 1/20 0.46
CYP2D6 P10635 1/20 0.46
DRD3 P35462 1/20 0.46
SCN1A P35498 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KCNH2 Q12809 1/20 0.46
SCN2A Q99250 1/20 0.46
SCN3A Q9NY46 1/20 0.46
MAOA P21397 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TSHR P16473 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PDE4D Q08499 1/20 0.42
ALDH1A1 P00352 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7451762 0.86 SMN1; SMN2 (0.58) CYP3A4CYP1A2GAASMN1; SMN2CYP2C9
SCHEMBL15264296 0.81 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1MAPK1TDP1NPC1
SCHEMBL8911435 0.81 SMN1; SMN2 (0.54) CYP1A2GAASMN1; SMN2TSHRCYP2C19
SCHEMBL143242 0.80 CYP3A4 (0.61) CYP3A4CYP1A2LMNACHRM2HTR1A
SCHEMBL8391475 0.78 ALDH1A1 (0.50) CYP3A4CYP1A2LMNAGAACYP2D6
SCHEMBL7337399 0.78 LTA4H (0.54) TSHRALDH1A1MAPTPPARGLTA4H
SCHEMBL5452821 0.78 CNR2 (0.49) LMNAGAASMN1; SMN2TSHRALDH1A1
SCHEMBL8993946 0.78 CYP1A2 (0.46) CYP3A4CYP1A2LMNACHRM2HTR1A
Hydrochloric Acid SCHEMBL6657541 0.78 CYP3A4 (0.59) CYP3A4CYP1A2LMNACHRM2HTR1A
Hydrochloric Acid SCHEMBL5697631 0.78 CYP3A4 (0.59) CYP3A4CYP1A2LMNACHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020128488-A1 Azomethine compound and oily magenta ink FUJI PHOTO FILM CO., LTD. 2002-09-12 US disclosed
EP-1035172-A2 Azomethine compound and oily magenta ink FUJI PHOTO FILM CO., LTD. (JP) 2000-09-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128488-A1 Azomethine compound and oily magenta ink IK, RB1, TYR CYP3A4 234/4885CYP1A2 45/4885LMNA 3731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.